Back in June of 2009 I had the opportunity to speak with Rob Lyles from Cook Medical about the treatment of PAD (peripheral arterial disease) and prior my interview I had no idea what PAD was. Cook Medical stents do not use polymers, but rather relies on smooth muscle cells to mold with the arteries...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Jan 23 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, healthcare, clinical trials, Cook Medical, arteries, leg therapy, peripheral intervention, PAD, Zilver PTX, impregnated catheters
2 additional size catheters have been added and a hospital acquired infection is every patient’s and doctor’s nightmare. Minocycline/rifampin is the antibiotic drug impregnated on the catheter. BD Press Release: Bloomington, Ind. – September 20, 2010 – Responding to increased demand...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Sep 20 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, FDA, Cook Medical, Antibiotics, Procedures, hospital acquired infections, infections, impregnated catheters
A while back I did an interview with Cook Medical, another company that makes the leg stents and is NOT part of this recall and I learned quite a bit. One other item worth mentioning here too is the fact that sometimes getting the patients to come back and have them removed is a chore. Doctors...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Aug 11 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, healthcare, FDA, clinical trials, Cook Medical, arteries, leg therapy, peripheral intervention, PAD, Zilver PTX, impregnated catheters
Cook Medical is presenting some very interesting and favorable numbers in reference to their clinical trials. If you check in here often enough you will find all kinds of information about Cook Medical and frankly I have learned more about stents, PAD, Leg Therapy and more than I ever thought...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Jan 20 2010
Filed under:
Filed under: Medically Related, Technology, healthcare, clinical trials, Cook Medical, arteries, leg therapy, peripheral intervention, PAD, Zilver PTX, impregnated catheters, interview
Press release below from Cook Medical with self-expanding metal stents with some interesting results as relates to patient care and effectiveness. You can read more about the Zilver Stents at the links below and and my interview with Rob Lyles, VP of the Cook Intervention Division, we need to know...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Dec 7 2009
Filed under:
Filed under: Medically Related, Technology, healthcare, clinical trials, Cook Medical, arteries, leg therapy, peripheral intervention, PAD, Zilver PTX, impregnated catheters
The stent is coated with paclitaxel, a cancer drug. The drug lasts in the body for 6-8 weeks, and is used to help prevent infections as well as decrease the chance of the body rejecting the stent. Our bodies are designed to heal and regrow tissue, so the drug also helps in that process with...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Aug 12 2009
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, clinical trials, Cook Medical, arteries, leg therapy, peripheral intervention, PAD, Zilver PTX, impregnated catheters
Not too long ago I had an extensive interview with the Leg Therapies Division of Cook Medical too, follow the link below for the full story. Cook Medical Interview Discussing PAD Leg Therapies– Rob Lyles, VP Peripheral Intervention Division “I posed Rob with a scenario, and asked whether I would...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Jul 16 2009
Filed under:
Filed under: Medically Related, Insurance, Other Items of Interest, healthcare, clinical trials, Cook Medical, arteries, leg therapy, peripheral intervention, PAD, Zilver PTX, impregnated catheters
Recently I had the opportunity to speak with Rob Lyles, vice president of the Peripheral Intervention division of Cook Medical. Just a few months ago Cook announced their new MicroWire technology for PAD (Peripheral Arterial Disease). We have pretty much all heard about catheter technology...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Jun 18 2009
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, clinical trials, Cook Medical, arteries, leg therapy, peripheral intervention, PAD, Zilver PTX, impregnated catheters